A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Clinical Trials, High Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06085664
Phase: PHASE1|PHASE2
Trial Summary: To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer. – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): M.D. Anderson Cancer Center
Acronym:

Pin It on Pinterest